HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.61

Change

+0.03 (+0.35)%

Market Cap

N/A

Volume

1.05K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.40 (+1.17%)

CAD 6.78B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 6.30B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.09 (+0.38%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.46 (+1.30%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.41 (+0.90%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 3.55B
PSLV-U:CA Sprott Physical Silver Trust

-0.04 (-0.34%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.01 (-0.04%)

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.26% 87% B+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.26% 87% B+ 78% C+
Trailing 12 Months  
Capital Gain -2.60% 11% F 20% F
Dividend Return 3.32% 69% C- 58% F
Total Return 0.71% 12% F 20% F
Trailing 5 Years  
Capital Gain 36.45% 38% F 38% F
Dividend Return 49.00% 90% A- 84% B
Total Return 85.45% 48% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 3.48% 50% F 44% F
Dividend Return 4.29% 51% F 41% F
Total Return 0.81% 79% B- 35% F
Risk Return Profile  
Volatility (Standard Deviation) 7.28% 68% D+ 84% B
Risk Adjusted Return 58.98% 66% D+ 67% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike